The objective of this study was to compare the effectiveness of sentinel lymph node biopsy (SLNB) and no SLNB on (1) short- and long-term complications and (2) long-term outcomes in women over age 67 diagnosed with DCIS who underwent breast-conserving surgery.

Project page: Comparing Treatment for Ductal Carcinoma In Situ (DCIS) with or without Sentinel Lymph Node Biopsy
Principal Investigator: Shiyi Wang, MD, PhD
Organization: Yale University
Original project title: Comparative Effectiveness of Sentinel Lymph Node Biopsy for Ductal Carcinoma In Situ
HSRProj ID: 20163062
ClinicalTrials.gov ID: NCT02908178

To cite this document, please use: Wang S-Y, Hung, P, Killelea BK, et al. (2020). Comparing Treatment for Ductal Carcinoma In Situ (DCIS) With or Without Sentinel Lymph Node Biopsy. Patient-Centered Outcomes Research Institute (PCORI). https://doi.org/10.25302/06.2020.CER.150731630

Tags

Resource Type

What's Happening at PCORI?

The Patient-Centered Outcomes Research Institute sends weekly emails highlighting results of our funded studies, newly funded research and engagement awards, opportunities to apply for funding, stakeholder workshops, and original feature stories about our funded projects.

Sign Up for Updates

Image

Hand pointing to email icon